EMILY GARZA: Open Payments
NPI 1235332529 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 9 companies in 2025. Trend: 2023 $101 · 2024 $261 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
Products named: LUTATHERA, ENHERTU, LIBTAYO, KISQALI, KEYTRUDA, Lenvima, JAKAFI, CABOMETYX.
Industry payments across AR — which companies pay providers there.
